Asset Details
Do you wish to reserve the book?
Myocarditis after Covid-19 Vaccination in a Large Health Care Organization
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Myocarditis after Covid-19 Vaccination in a Large Health Care Organization
Do you wish to request the book?
Myocarditis after Covid-19 Vaccination in a Large Health Care Organization
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Myocarditis after Covid-19 Vaccination in a Large Health Care Organization
2021
Overview
Among 2.5 million patients who received the BNT162b2 mRNA vaccine in a large Israeli health care system, the incidence of myocarditis at 42 days was 2.13 cases per 100,000 persons, with the highest incidence (10.69 per 100,000 persons) among male patients between the ages of 16 and 29 years. Most cases of myocarditis were mild or moderate.
Publisher
Massachusetts Medical Society
Subject
/ Adult
/ BNT162 Vaccine - adverse effects
/ COVID-19
/ COVID-19 - prevention & control
/ Disease
/ Female
/ Hospitalization - statistics & numerical data
/ Humans
/ Male
/ mRNA
/ Original
/ Patients
/ Severe acute respiratory syndrome coronavirus 2
/ Vaccines
/ Ventricular Dysfunction, Left - epidemiology
